News
BNR
17.93
+13.16%
2.09
Aurelion appoints Yuki Xu acting chief accounting officer, replacing Hattie He
PUBT · 11h ago
Weekly Report: what happened at BNR last week (0406-0410)?
Weekly Report · 21h ago
Weekly Report: what happened at BNR last week (0330-0403)?
Weekly Report · 04/06 10:15
Insider Makes Bold Multi-Million Dollar Bet on Burning Rock Biotech
TipRanks · 04/03 02:05
Burning Rock director Han Yusheng buys USD 5.5 million in common shares
Reuters · 04/02 11:18
Burning Rock Biotech founder and CEO purchases company ADSs
TipRanks · 04/02 10:44
Burning Rock founder Han buys ADSs worth US$1.4 million
Reuters · 04/02 10:26
Burning Rock Announces Founder’s Purchase of Its ADSs
Barchart · 04/02 05:25
Weekly Report: what happened at BNR last week (0323-0327)?
Weekly Report · 03/30 10:15
Weekly Report: what happened at BNR last week (0316-0320)?
Weekly Report · 03/23 10:12
Burning Rock Biotech Director Deng Feng Files Initial Beneficial Ownership Statement
Reuters · 03/19 00:18
Burning Rock Biotech Ltd. files Form 3 as director Wendy W. Hayes reports no beneficial ownership
Reuters · 03/17 14:11
Burning Rock Biotech Director Han Yusheng Files Initial Beneficial Ownership Statement
Reuters · 03/17 14:09
Burning Rock Biotech Director Zhang Zhihong Files Initial Beneficial Ownership Statement
Reuters · 03/17 14:00
Burning Rock Biotech files Form 3 initial beneficial ownership statement for Senior Director in Finance Hu Xiaozhi
Reuters · 03/17 13:51
Burning Rock Biotech Director Xu Licen Lisa Files Initial Beneficial Ownership Statement
Reuters · 03/17 13:45
Weekly Report: what happened at BNR last week (0309-0313)?
Weekly Report · 03/16 10:11
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 03/13 17:06
Burning Rock Biotech Narrows Loss and Lifts Margins on 2025 Results as Oncology Portfolio Advances
TipRanks · 03/13 10:55
Burning Rock Biotech GAAP EPS of -$0.02, revenue of $18.1M
Seeking Alpha · 03/12 19:45
More
Webull provides a variety of real-time BNR stock news. You can receive the latest news about Burning Rock Biotech Ltd through multiple platforms. This information may help you make smarter investment decisions.
About BNR
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.